LYRA THERAPEUTICS INC

CUSIP: 55234L105 Class: Common Stock

BRIDGEWAY CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001107261)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 86,800 Value ($000) $540 Avg Close Range
Q4 2023
Shares 141,800 Value ($000) $743 Avg Close Range
Q3 2023
Shares 141,800 Value ($000) $554 Avg Close Range
Q2 2023
Shares 96,800 Value ($000) $398 Avg Close Range
Q1 2023
Shares 146,800 Value ($000) $304 Avg Close Range
Q4 2022
Shares 146,800 Value ($000) $461 Avg Close Range
Q3 2022
Shares 56,900 Value ($000) $285 Avg Close Range
Q2 2022
Shares 56,900 Value ($000) $321 Avg Close Range
Q1 2022
Shares 66,900 Value ($000) $269 Avg Close Range
Q4 2021
Shares 66,900 Value ($000) $292 Avg Close Range
Q3 2021
Shares 68,900 Value ($000) $630 Avg Close Range
Q2 2021
Shares 41,900 Value ($000) $336 Avg Close Range
Q1 2021
Shares 49,000 Value ($000) $568 Avg Close Range
Q4 2020
Shares 49,000 Value ($000) $559 Avg Close Range